We are live on ! Find out more
TGI

TRV GP IV Portfolio holdings

AUM $267M
1-Year Est. Return 965.83%
This Fund
S&P 500
This Quarter Est. Return
-38.94%
1 Year Est. Return
+965.83%
3 Year Est. Return
+686.22%
5 Year Est. Return
+581.56%
10 Year Est. Return
AUM
$92.9M
AUM Growth
+$12.7M
Cap. Flow
+$73.1M
Cap. Flow %
78.75%
Top 10 Hldgs %
100%
Holding
3
New
1
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
MAZE
Maze Therapeutics
MAZE
+$73.1M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAZE
1
Maze Therapeutics
MAZE
$1.49B
$66.9M 72.02%
+6,073,958
New +$73.1M
TNGX icon
2
Tango Therapeutics
TNGX
$4.43B
$23.1M 24.88%
16,859,075
PLRX icon
3
Pliant Therapeutics
PLRX
$64.4M
$2.88M 3.1%
2,132,867

Similar funds

TRV GP IV's Q1 2025 Portfolio in Review

As of Q1 2025, TRV GP IV held 3 positions worth $92.9M, up 16% from $80.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

TRV GP IV deployed $73.1M of net new capital in Q1 2025, opening 1 new position. Its largest new stake was Maze Therapeutics: 6,073,958 shares worth $66.9M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • TRV GP IV's largest Q1 2025 buy was Maze Therapeutics: 6,073,958 shares worth $66.9M.
  • TRV GP IV's ten largest holdings make up 100% of its $92.9M portfolio in Q1 2025.
  • TRV GP IV opened 1 new position and closed 0 in Q1 2025.
  • TRV GP IV's portfolio value rose 16% quarter-over-quarter to $92.9M.

Based on TRV GP IV's 13F filing for Q1 2025, filed 9 May 2025.